Who is sponsoring NCT04950257?

NCT04950257 is sponsored by University of Exeter.

What condition does NCT04950257 study?

NCT04950257 studies Rumination, Worry, Repetitive Negative Thinking.

Is NCT04950257 still recruiting?

NCT04950257 is currently completed. Last updated 1 February 2022.

Last reviewed 2022-02-01 · How we verify

NCT04950257

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluating the Effects of a Self-help Mobile Phone Application on Worry and Overthinking in Young Adults Aged Between 16 and 24.

Completed NA Last updated 1 February 2022

What this trial tests

NA trial testing digital CBT self-help including specific intervention elements to target worry and rumination. in Rumination in 236 participants. Completed in 30 January 2022.

Timeline

14 May 2021

Primary endpoint
13 December 2021

30 January 2022

Quick facts

Lead sponsor	University of Exeter
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	236
Start date	14 May 2021
Primary completion	13 December 2021
Estimated completion	30 January 2022
Sites	1 location across United Kingdom

Drugs / interventions tested

digital CBT self-help including specific intervention elements to target worry and rumination.

Conditions studied

Rumination — all drugs for Rumination →
Worry — all drugs for Worry →
Repetitive Negative Thinking — all drugs for Repetitive Negative Thinking →

Sponsor

University of Exeter

Who can join

Adults 16 to 24, any sex, with Rumination or Worry. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project seeks to understand if a new self-help mobile phone application (called MyMoodCoach) is effective at reducing worry and overthinking, prominent risk factors that predict reduced well-being and poor mental health. As a primary outcome, the investigators are predicting that people who use the app will report more significant reductions on measures of overthinking than those who do not. The investigators also predict that people who use the app will report more significant reductions in measures of worry as well as reported symptoms of depression and anxiety. Further, it is predicted that people who use the app will report a significantly higher increase in their well-being compared to those who do not.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Reducing worry and rumination in young adults via a mobile phone app: study protocol of the ECoWeB (Emotional Competence for Well-Being in Young Adults) randomised controlled trial focused on repetitive negative thinking.
Edge D, Newbold A, Ehring T, Rosenkranz T, et al · · 2021 · cited 7× · PMID 34674669 · DOI 10.1186/s12888-021-03536-0
Evaluating the Effects of a Self-Help Mobile Phone App on Worry and Rumination Experienced by Young Adults: Randomized Controlled Trial.
Edge D, Watkins E, Newbold A, Ehring T, et al · · 2024 · cited 4× · PMID 39137411 · DOI 10.2196/51932

Verify or expand the search:

Other recruiting trials for Rumination

Currently open trials in the same condition.

NCT07478393 — Readiness and Progress in Emotion Regulation Therapy · NA · recruiting
NCT07189715 — Optimization of Imagery Rescripting Research Using Generative Artificial Intelligence · NA · recruiting
NCT06937476 — Neurobiological Mechanisms of Pathological Rumination and Effects of Aripiprazole · NA · active not recruiting
NCT06828276 — Culturally Adapted i-CBT for Farsi/Dari Speaking Migrants · NA · recruiting
NCT05617495 — Mindfulness-Based fMRI Neurofeedback for Depression · NA · recruiting

Other University of Exeter trials

Trials by the same sponsor.

NCT07457437 — Function and Lean Mass Preservation With Resistance Exercise During a GLP-1RA Treatment · NA · recruiting
NCT06478121 — Understanding Beta Cell Disorders Through the Study of Rare Genotypes (ENDURE) · recruiting
NCT06965699 — The Effect of a Plant-based, Protein-dense Sauce on Essential Amino Acid Concentrations and Gut Fullness in Older Adults · NA · recruiting
NCT06846294 — Obesity Prevention in Children and Young People Treated for Acute Lymphoblastic Leukaemia with ALLTogether · NA · not yet recruiting
NCT06852547 — The Effect of Ingesting a Novel Algae Protein Source on Rested and Exercised Muscle Protein Synthesis Rates in Older Adu · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04950257 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Exeter
Last refreshed: 1 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04950257.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing